Prescription generation is one of the most important—and most difficult—activities in ethical pharmaceutical marketing.

A pharmaceutical company may have:

• Good products
• Attractive packaging
• Competitive pricing
• A large sales team
• Strong distribution

But prescription-based products will not grow sustainably unless doctors understand the product, trust its quality and consider it appropriate for suitable patients.

Prescription generation should therefore not mean “getting a doctor to write a brand at any cost.”

A better definition is:

Prescription generation is the process of building sufficient scientific, professional and product confidence so that a qualified healthcare professional chooses a brand for an appropriate patient on its clinical merits.

This distinction is extremely important.

Modern pharmaceutical marketing must combine:

• Scientific communication
• Product quality
• Ethical promotion
• Consistent doctor coverage
• Availability
• Patient affordability
• Professional follow-up

Quick Answer: Six Effective Prescription Generation Methods

The six most useful methods are:

1. Regular and Scientific Doctor Calls
2. Strong Product Differentiation and Evidence-Based Detailing
3. CME, CPD and Scientific Engagement
4. Properly Controlled Medical Samples
5. Strong Product Availability, Distribution and Affordability
6. Consistent Follow-Up, Feedback and Relationship Management

These methods work together.

A good product without regular follow-up may be forgotten.

Regular calls without scientific content may irritate doctors.

Good detailing without product availability may generate prescriptions that cannot be fulfilled.

Successful prescription marketing therefore requires a complete system.

1. Regular and Scientific Doctor Calls

Doctor calls remain the foundation of pharmaceutical prescription marketing.

A doctor call occurs when a Medical Representative, Business Executive or sales professional meets a healthcare professional to provide approved information about the company’s products.

The purpose should be to:

• Explain the product
• Communicate approved indications
• Discuss dosage and administration
• Explain important precautions
• Provide scientific information
• Answer legitimate questions
• Introduce new formulations
• Provide approved literature
• Obtain market feedback

Why Regular Doctor Calls Work

Doctors deal with hundreds or thousands of medicines.

A pharmaceutical company needs consistent professional communication so that its brand remains familiar.

However, “regular” does not mean excessive visits.

Repeatedly visiting a doctor’s clinic without useful information may:

• Waste the doctor’s time
• Irritate clinic staff
• Reduce brand credibility
• Damage the representative’s relationship

The objective should be quality of communication, not merely the number of calls.

How Often Should a Doctor Be Visited?

There is no single frequency suitable for every doctor.

Call frequency should depend on:

• Doctor potential
• Specialty
• Product relevance
• Territory
• Previous response
• Product launch stage
• Company’s call plan

A high-priority doctor may require more frequent professional follow-up than a low-potential doctor.

What Makes a Good Doctor Call?

A good representative should know:

• Brand name
• Generic composition
• Strength
• Approved indication
• Dosage
• Mechanism of action
• Contraindications
• Important adverse effects
• Drug interactions
• Product positioning
• Clinical evidence
• Relevant competing therapies

A representative should never invent an answer.

If the doctor asks something the representative cannot answer confidently, the better response is to obtain accurate information from the medical or regulatory department and follow up later.

2. Strong Product Differentiation and Evidence-Based Detailing

Doctors already have numerous treatment choices.

Simply saying:

“Doctor, please prescribe my brand.”

provides no clinical reason to change behaviour.

The representative should be able to explain:

“Why should this product be considered for an appropriate patient?”

Product Differentiation May Come From

• Formulation
• Strength
• Dosage convenience
• Release technology
• Dosage form
• Stability
• Palatability
• Packaging
• Patient convenience
• Quality standards
• Evidence
• Cost of therapy
• Availability

The claimed advantage must be genuine and supportable.

New Molecules Can Help—but “New” Is Not Enough

A newer molecule may receive attention when it offers a meaningful clinical advantage.

However, a product should not be promoted simply because it is new.

Doctors may ask:

• Is it more effective?
• Is it safer?
• For which patients?
• What evidence supports it?
• What are the contraindications?
• How does it compare with existing therapy?
• What is the cost?
• Is it readily available?

A representative must be prepared for these questions.

Mature Molecules Can Also Build Strong Brands

A company does not necessarily need a newly patented molecule.

Even an established molecule can grow when the company provides:

• Reliable quality
• Consistent supply
• Appropriate pricing
• Strong scientific communication
• Convenient dosage form
• Patient-friendly packaging

The objective should be meaningful differentiation rather than artificial novelty.

Prepare a Product Dossier Before Entering the Market

Before launching any prescription product, prepare a detailed internal product report.

It should cover:

Product Information

• Brand name
• Generic name
• Composition
• Strength
• Dosage form
• Pack size
• Approved indication

Clinical Information

• Pharmacological class
• Mechanism of action
• Dosage
• Administration
• Contraindications
• Precautions
• Adverse effects
• Drug interactions
• Special populations

Market Information

• Market size
• Market growth
• Major competitors
• Leading brands
• Price comparison
• Therapy trends
• Prescribing specialties

Positioning

Define:

• Target doctor
• Target patient
• Main product benefit
• Supporting evidence
• Key objection
• Approved response
• Core detailing message

This document becomes useful for:

• MR training
• Visual-aid development
• Product launches
• Sales meetings
• Objection handling
• Scientific communication

3. CME, CPD and Scientific Engagement

Doctors need continuous professional education because medical knowledge evolves continuously.

Scientific engagement may include:

• Continuing Medical Education
• Continuing Professional Development
• Seminars
• Workshops
• Scientific conferences
• Webinars
• Clinical discussions
• Expert panels
• Research presentations

These activities can help pharmaceutical companies build scientific credibility when organised transparently and compliantly.

Why Scientific Meetings Are Effective

They allow healthcare professionals to:

• Understand new evidence
• Review treatment guidelines
• Discuss difficult clinical cases
• Learn from specialists
• Compare therapeutic approaches
• Stay updated with medical science

A pharmaceutical company’s role should be to support legitimate scientific education—not purchase prescriptions.

Conferences Should Never Become Prescription Deals

The wrong approach is:

“We sponsored your conference, so you should prescribe our product.”

Scientific support should never be conditional on:

• Number of prescriptions
• Brand commitment
• Sales generated
• Switching from a competitor
• Minimum monthly business

That converts scientific education into an inducement.

Foreign Leisure Tours Are Not a Marketing Method

Older pharmaceutical marketing practices sometimes included:

• Foreign holidays
• Family tours
• Resort stays
• Cruise tickets
• Luxury travel

These should not be treated as acceptable prescription-generation strategies.

Scientific engagement must follow current pharmaceutical marketing rules and internal compliance procedures.

4. Properly Controlled Medical Samples

Medical samples can be useful when provided appropriately.

The objective of a free medical sample is to allow a qualified healthcare professional to become familiar with a product and its use.

Samples should not function as gifts.

How Samples Can Support Prescription Generation

A doctor may use a sample to:

• Become familiar with a new dosage form
• Assess patient acceptability
• Understand packaging
• Start appropriate treatment in a selected situation
• Become familiar with administration

If the doctor’s experience is satisfactory and the product is clinically appropriate, the doctor may subsequently consider the brand.

Sample Distribution Should Be Controlled

The company should maintain records covering:

• Product name
• Doctor
• Quantity
• Date
• Representative
• Batch information where required
• Value of samples

Sample packs should carry the appropriate:

“Free Medical Sample – Not for Sale”

declaration.

Samples Should Not Be Used As

• Personal gifts
• Retail stock
• Cash substitutes
• Rewards for prescribing
• Incentives for increasing prescription volume

The purpose must remain legitimate product familiarisation.

5. Strong Availability, Distribution and Patient Affordability

Generating a prescription is not enough.

Imagine a doctor prescribes your product and the patient visits three pharmacies but cannot find it.

The result may be:

1. Pharmacist substitutes another brand.
2. Patient returns to the doctor.
3. Doctor loses confidence in your availability.
4. Future prescriptions decline.

That is why prescription generation and distribution must work together.

Ensure Availability Around Important Doctors

Identify:

• Nearby pharmacies
• Main stockists
• Distributors
• Hospital pharmacies
• High-volume retailers

Ensure appropriate stock is available without forcing excessive inventory on retailers or distributors.

Track Prescription-to-Supply Conversion

The sales team should investigate:

• Is the product available?
• Are retailers ordering it?
• Is the distributor maintaining inventory?
• Is there frequent stockout?
• Is a competitor being substituted?
• Is the patient’s price objection high?

Patient Affordability Matters

Price can influence whether a patient:

• Starts therapy
• Completes therapy
• Buys the prescribed brand
• Asks for an alternative

Companies should evaluate the cost of therapy, not merely MRP.

For example:

Cost per day = Price paid by patient ÷ number of treatment days

Two products with similar MRPs may have very different daily treatment costs.

Legitimate Commercial Pricing Is Different from Paying for Prescriptions

Hospitals, distributors and pharmacies may negotiate legitimate commercial rates, discounts or institutional supply terms.

But pricing should be:

• Transparent
• Properly invoiced
• Commercially justified
• Consistent with applicable law

It should never be converted into a personal cash payment or commission to an individual doctor in exchange for prescriptions.

6. Consistent Follow-Up, Feedback and Professional Relationship Management

The first doctor call rarely creates a successful brand.

Prescription development usually occurs gradually.

A representative may need to:

1. Introduce the product.
2. Explain the evidence.
3. Leave approved literature.
4. Answer questions.
5. Follow up.
6. Confirm availability.
7. Receive feedback.
8. Address objections.
9. Reinforce the appropriate product positioning.

Ask for Feedback, Not Prescription Guarantees

Useful questions include:

• “Doctor, have you had an opportunity to use this formulation?”
• “What has been your experience?”
• “Are there any concerns about the dosage?”
• “Do you need further information on the evidence?”
• “Are patients facing any availability issue?”

This creates a professional discussion.

Keep Proper Doctor Profiles

A CRM or doctor profile may contain:

• Specialty
• Clinic location
• Relevant therapy interests
• Preferred call timing
• Products detailed
• Scientific questions
• Follow-up required
• Product availability around the clinic

Do not record inappropriate personal information unrelated to legitimate professional interaction.

Relationship Does Not Mean Inducement

A strong doctor relationship should be based on:

• Reliability
• Knowledge
• Respect
• Professional communication
• Accurate information
• Timely follow-up
• Product quality
• Service

It should not be based on:

• Cash
• Commissions
• Expensive gifts
• Personal benefits
• Family travel
• Prescription targets assigned to a doctor

Methods That Should NOT Be Used for Prescription Generation

Older pharmaceutical marketing discussions frequently described certain practices as a normal part of business.

They should no longer be recommended.

1. Cash Against Prescription

Giving a doctor:

• Cash
• Percentage commission
• Monthly payment
• Prescription-linked incentive
• Monetary grant

in exchange for prescribing a product is not an acceptable pharmaceutical marketing method.

2. Luxury Gifts

Do not use items such as:

• Expensive electronics
• Luxury watches
• Vehicles
• Personal household goods
• Premium personal accessories

as prescription inducements.

3. Leisure and Family Tours

Paid vacations or travel for a healthcare professional or family members should not be used as a prescription-generation strategy.

4. Prescription-Linked Conference Sponsorship

Scientific participation should not depend on:

“Write X prescriptions and we will sponsor your conference.”

5. Fake Clinical Evidence

Never:

• Invent trials
• Manipulate statistics
• Misquote research
• Hide material safety information
• Present promotional material as independent research

6. Off-Label Promotion

A drug should not be promoted for an indication that is outside its approved marketing authorisation.

Prescription Generation vs Prescription Buying

These concepts should never be confused.

Prescription Generation

Built through:

• Product merit
• Scientific information
• Quality
• Evidence
• Availability
• Professional follow-up

Prescription Buying

Attempts to obtain prescriptions through:

• Cash
• Commission
• Personal gifts
• Trips
• Personal financial benefits

The first creates a sustainable pharmaceutical brand.

The second creates regulatory, ethical and reputational risk.

Business and Marketing Plan for Prescription Products

Suppose a company plans to launch 20 products.

Do not send representatives into the market with only:

• Brand names
• MRPs
• Visual aids

Prepare a strategy for every important product.

Step 1: Understand the Molecule

Study:

• Drug class
• Generation
• Mechanism
• Indications
• Dosage
• Contraindications
• Side effects
• Interactions
• Important precautions

Step 2: Understand the Market

Analyse:

• Market size
• Growth
• Top brands
• Competitors
• Price
• Prescription trends

Step 3: Identify the Target Specialty

Determine who is most likely to prescribe the product.

Examples:

• General physicians
• Paediatricians
• Gynaecologists
• Orthopaedic surgeons
• Cardiologists
• Diabetologists
• Dermatologists
• Neurologists

Do not promote every product to every doctor.

Step 4: Define the Product Positioning

Answer in one sentence:

“For which appropriate patient should the doctor consider this brand, and why?”

If the sales team cannot answer this clearly, the marketing strategy is incomplete.

Step 5: Prepare Approved Communication

Develop:

• Visual aid
• Product monograph
• Literature
• Leave-behind card
• FAQ sheet
• Objection-handling guide

Step 6: Train the Field Force

Medical Representatives should be trained on:

• Product
• Disease
• Competition
• Evidence
• Safety
• Compliance
• Doctor communication

Step 7: Ensure Distribution Before Promotion

Make sure the product is available before large-scale prescription activity begins.

Step 8: Measure the Right Indicators

Do not measure success only through primary dispatch.

Track:

• Secondary sales
• Repeat orders
• Retail availability
• Product-wise growth
• Doctor coverage
• Call quality
• Stockouts
• Returns
• Expiry
• Feedback

Prescription Generation for a New Pharma Company

A new company should not try to compete simultaneously with large established companies across hundreds of products.

A better strategy is to select:

• A focused therapy area
• A limited product range
• Selected doctors
• A manageable territory

For example, instead of marketing 50 unrelated products, a startup may select 8–15 products focused on:

• Orthopaedics
• Gynaecology
• Paediatrics
• Gastroenterology
• General medicine

This allows:

• Better product knowledge
• Better doctor targeting
• Lower inventory
• More focused promotion
• Easier availability management

How Long Does Prescription Generation Take?

There is no fixed period.

Results depend on:

• Product
• Doctor
• Competition
• Brand familiarity
• Representative quality
• Price
• Availability
• Clinical need
• Frequency of calls

Some products may receive early trials.

Others require repeated scientific interaction.

Prescription marketing should therefore be evaluated over a reasonable period rather than expecting immediate results after one doctor visit.

Role of the Medical Representative

A Medical Representative should act as a professional communication link between the pharmaceutical company and healthcare professionals.

The role includes:

• Product detailing
• Scientific communication
• Providing approved literature
• Providing authorised samples
• Answering questions
• Reporting feedback
• Ensuring product availability
• Reporting complaints
• Reporting adverse-event information according to company procedure

An MR should not be trained merely to “extract prescriptions.”

Frequently Asked Questions

1. What is prescription generation in pharma?

It is the process of creating awareness and professional confidence among healthcare professionals so that an appropriate pharmaceutical product may be prescribed to suitable patients.

2. What is the most effective prescription-generation method?

Regular, well-planned doctor calls supported by accurate scientific information and consistent product availability remain among the most important methods.

3. Can pharma companies give cash to doctors for prescriptions?

No. Cash or monetary benefits should not be used as an inducement for prescribing pharmaceutical products.

4. Can pharma companies sponsor foreign tours for doctors?

Foreign leisure travel or paid vacations should not be used as prescription incentives. Current pharmaceutical marketing rules place significant restrictions on travel and hospitality.

5. Can pharmaceutical companies organise CME programs?

Yes, scientific CME and CPD engagement is possible when conducted through transparent and compliant arrangements under applicable rules.

6. Are free medicine samples allowed?

Free medical samples may be provided subject to applicable restrictions, proper labelling and accountability.

7. Does a new molecule automatically generate prescriptions?

No. Newness alone is not sufficient. The product must have a clinically meaningful and supportable position.

8. Why is product availability important?

A doctor’s prescription may be lost if the patient cannot obtain the product from nearby pharmacies.

9. Should doctors be visited every day?

No. Call frequency should be appropriate to the doctor, product and territory. Excessive visits may become counterproductive.

10. Should a Medical Representative promise that a drug has no side effects?

No. Pharmaceutical communication must provide accurate and balanced information.

11. Can a doctor be paid commission on MRP or PTR?

A personal prescription-linked commission is not a legitimate substitute for normal trade pricing and should not be used to induce prescriptions.

12. What should a startup focus on first?

Start with a focused product range, strong product knowledge, selected doctors, reliable distribution and regular professional follow-up.

Final Thoughts

Prescription generation should never be reduced to:

Money → Doctor → Prescription → Sale

A sustainable pharmaceutical business works differently:

Quality product → Scientific communication → Doctor confidence → Patient suitability → Availability → Repeat use

Successful brands are built when:

• Representatives are knowledgeable
• Claims are credible
• Doctors are respected
• Products are available
• Prices are reasonable
• Follow-up is consistent
• Marketing remains ethical

There is no shortcut that replaces these fundamentals.

Looking for Ayurvedic Franchise or Distribution Opportunities?

Elzac Herbal India offers opportunities for entrepreneurs interested in Ayurvedic and herbal product distribution, franchise marketing and third-party manufacturing.

Elzac Herbal India offers:

• Ayurvedic & Herbal Product Range
• Franchise & Distribution Opportunities
• Third-Party Manufacturing
• Product Development Support
• Marketing Guidance
• PAN India Business Opportunities

Whether you are an entrepreneur, retailer, distributor, or healthcare professional, our team can help you explore the right business opportunity in the growing Ayurvedic sector.

Contact us today to discuss ayurvedic franchise, distribution, or third-party manufacturing opportunities.